Evidence suggests commercial health plans are more likely to delay specialty drug coverage decisions in response to FDA ...

In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This ...

Prescribing antidepressants for off-label indications is often not supported by strong evidence For many off-label indications, the prescribed drug is often not supported by strong evidence for the ...

We're likely to believe that if our doctor prescribes us a drug, it's exactly what we need. But a new study warns this is hardly the case. Most off-label antidepressant prescriptions lack strong ...

off label button Clinicians who prescribe gabapentin for off-label uses should assess available evidence for a given indication. Clinicians who prescribe gabapentin for off-label uses should assess ...